Metraipolis › archive › dc_223d7e69fa65
Disease burden of myasthenia gravis in relation to oral corticosteroid dose: an insurance claims database study in Japan — Europe PMC PMID:41200439
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41200439
- DOI
- 10.3389/fneur.2025.1662173
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T03:25:43.916Z
- SHA-256 of the archived text
e32c486c462f62ba28034f629bddd88fd436cef5b63deadf3aa68e6404e8f0fe- Stable URL of this page
https://metraipolis.com/documento/dc_223d7e69fa65
How to cite
Disease burden of myasthenia gravis in relation to oral corticosteroid dose: an insurance claims database study in Japan — Europe PMC PMID:41200439 — Europe PMC (en), https://europepmc.org/article/MED/41200439 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_223d7e69fa65 (Metraipolis archive dc_223d7e69fa65, sha256 e32c486c462f62ba28034f629bddd88fd436cef5b63deadf3aa68e6404e8f0fe)
BibTeX
@misc{dc223d7e69fa65,
title = {Disease burden of myasthenia gravis in relation to oral corticosteroid dose: an insurance claims database study in Japan — Europe PMC PMID:41200439},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41200439},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_223d7e69fa65; sha256 e32c486c462f62ba28034f629bddd88fd436cef5b63deadf3aa68e6404e8f0fe},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41200439. Agents can read the archived copy with the MCP tool read_document.